Literature DB >> 2131784

Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats.

U Katsumata1, M Miura, M Ichinose, K Kimura, T Takahashi, H Inoue, T Takishima.   

Abstract

Using 30 anesthetized cats, we examined whether oxygen radicals produce airway constriction or hyperresponsiveness. In one group, we administered aerosolized xanthine (0.1%) for 3 min followed by aerosolized xanthine oxidase (XO) (1 U/ml) for 5 min in order to generate oxygen radicals enzymatically in the airways. Pulmonary resistance (RL) instantaneously increased from 14.8 +/- 0.9 to 30.8 +/- 1.4 cm H2O/L/s (p less than 0.01). The increase in RL was significantly depressed by prior administration of polyethylene glycol-superoxide dismutase (PEG-SOD) or polyethylene glycolcatalase (PEG-CAT). In a second group, in order to examine changes in airway responsiveness, we studied acetylcholine (ACh) challenge before and 30, 60, and 120 min after inhalations of xanthine and XO. After xanthine-XO, the airways were hyperresponsive to ACh at 30 and at 60 min (p less than 0.05) but not at 120 min. The geometric means of ACh provocative concentrations that caused an increase in RL of 10 cm H2O/L/s above the baseline value before and 30, 60, and 120 min after xanthine-XO were 0.25, 0.045, 0.073, and 0.15%, respectively. The increase in responsiveness to ACh was significantly correlated with the increase in RL after xanthine-XO inhalation (r = 0.88, p less than 0.05). These data support the concept that oxygen radicals generated by xanthine-XO inhalation may induce bronchoconstriction and airway hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2131784     DOI: 10.1164/ajrccm/141.5_Pt_1.1158

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  24 in total

Review 1.  Oxidative stress in the pathogenesis of asthma.

Authors:  Russell P Bowler
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  Airway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidase.

Authors:  Pasquale Chitano; Lu Wang; Stanley N Mason; Richard L Auten; Erin N Potts; William M Foster; Anne Sturrock; Thomas P Kennedy; John R Hoidal; Thomas M Murphy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

Review 3.  Mitochondrial regulation of airway smooth muscle functions in health and pulmonary diseases.

Authors:  Shi Pan; Stanley Conaway; Deepak A Deshpande
Journal:  Arch Biochem Biophys       Date:  2019-01-08       Impact factor: 4.013

4.  PAF-induced muscarinic cholinoceptor hyperresponsiveness of ferret tracheal smooth muscle and gland secretion in vitro.

Authors:  S E Webber; T Morikawa; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

5.  Edaravone attenuates experimental asthma in mice through induction of HO-1 and the Keap1/Nrf2 pathway.

Authors:  Yuting Pan; Weihao Li; Ying Feng; Jing Xu; Huifang Cao
Journal:  Exp Ther Med       Date:  2019-12-19       Impact factor: 2.447

6.  Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.

Authors:  M Honma; G Tamura; K Shirato; T Takishima
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

7.  The effect of acute exposure to hyperbaric oxygen on respiratory system mechanics in the rat.

Authors:  Alessandro Rubini; Andrea Porzionato; Susi Zara; Amelia Cataldi; Giacomo Garetto; Gerardo Bosco
Journal:  Lung       Date:  2013-07-05       Impact factor: 2.584

8.  The effect of platelet-activating factor on the responsiveness of the human nasal airway.

Authors:  C E Austin; J C Foreman
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis.

Authors:  Sun-Young Nam; Hyun-A Oh; Youngjin Choi; Kun-Young Park; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  J Med Food       Date:  2014-08-04       Impact factor: 2.786

Review 10.  Theophylline. Current thoughts on the risks and benefits of its use in asthma.

Authors:  S S Nasser; P J Rees
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.